MarketPeel
Insider Trading Intelligence
Pricing
…
CS

Christine Berni Silverstein

ABEO
CHIEF FINANCIAL OFFICER · ABEONA THERAPEUTICS INC. · CIK 0001772546
FILING MIX · LIFETIME60%/40%
BUYS
18
SELLS
12
TOTAL VALUE
$694.8K
COMPANIES
1
ACTIVE SINCE
Mar 2020
HOLDINGS NOW
119,562
AVG SELL PX
$5.08
TRADE KIND
SHOWING 30 / 30
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
3 backtested trades · 8 horizons · 3 pending
Forward-return performance of every backtestable P/S trade by Christine Berni Silverstein, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d3+66.67%-0.84%-0.29%-0.55%-0.56%—
14d3+66.67%-1.40%+0.34%-1.74%-0.71%—
30d3+66.67%+0.28%-1.33%+1.61%-2.39%—
60d3+33.33%+8.28%+0.79%+7.49%+8.74%—
90d3+0.00%+20.34%+6.10%+14.24%+14.45%—
180d3(1 pending)+0.00%+58.30%+17.10%+41.20%+41.20%—
1y3(1 pending)+0.00%+40.95%+23.23%+17.73%+17.73%—
2y3(1 pending)+0.00%+30.91%+46.77%-15.86%-15.86%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ABEO · 119,562 shares · as of Jun 15, 2026
039,44878,896118,344157,792202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 18 buys / 12 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ABEO
ABEONA THERAPEUTICS INC.
SALE
18,160$5.71$103.7K119,562Jun 15, 2026Jun 15, 2026 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
SALE
20,070$5.09$102.2K137,722Feb 2, 2026Feb 2, 2026 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
37,313——157,792Jan 26, 2026Jan 27, 2026 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
SALE
13,093$5.86$76.7K120,479Jul 9, 2025Jul 10, 2025 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
36,101——133,572Jan 31, 2025Feb 3, 2025 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
11,797——97,471Aug 26, 2024Aug 27, 2024 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
23,611——85,674Jul 8, 2024Jul 9, 2024 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
SALE
25,821$4.51$116.5K62,063Jun 18, 2024Jun 20, 2024 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
SALE
6,330$3.91$24.7K87,884Sep 27, 2023Sep 29, 2023 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
58,689$4.62$271.1K94,214Jun 14, 2023Jun 16, 2023 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
13,400——35,525Sep 26, 2022Sep 28, 2022 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
38,590——118,590May 25, 2021May 27, 2021 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
49,084——49,084May 25, 2021May 27, 2021 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
SALE
80,000——0Nov 20, 2020Nov 20, 2020 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
35,000——35,000Nov 20, 2020Nov 20, 2020 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
SALE
35,000——0Nov 20, 2020Nov 20, 2020 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
80,000——80,000Nov 20, 2020Nov 20, 2020 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
102,163——102,163Nov 20, 2020Nov 20, 2020 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
93,750——93,750Nov 20, 2020Nov 20, 2020 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
SALE
57,837——0Nov 20, 2020Nov 20, 2020 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
20,000——20,000Nov 20, 2020Nov 20, 2020 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
SALE
75,000——0Nov 20, 2020Nov 20, 2020 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
SALE
20,000——0Nov 20, 2020Nov 20, 2020 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
57,837——57,837Nov 20, 2020Nov 20, 2020 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
SALE
102,163——0Nov 20, 2020Nov 20, 2020 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
SALE
93,750——0Nov 20, 2020Nov 20, 2020 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
75,000——75,000Nov 20, 2020Nov 20, 2020 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
57,837——57,837May 20, 2020May 22, 2020 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
80,000——80,000May 20, 2020May 22, 2020 ↗View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
102,163——102,163Mar 16, 2020Mar 18, 2020 ↗View →
Other insiders · ABEO
Loading peer insiders…
About this filer
CIK 0001772546
ROLE
Chief Financial Officer
PRIMARY
ABEO
COMPANIES
1
ACTIVE SINCE
Mar 2020
MARKETPEEL · /INSIDER/0001772546DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback